A citation-based method for searching scientific literature

Ranjit Manchanda, Matthew Burnell, Kelly Loggenberg, Rakshit Desai, Jane Wardle, Saskia C Sanderson, Sue Gessler, Lucy Side, Nyala Balogun, Ajith Kumar, Huw Dorkins, Yvonne Wallis, Cyril Chapman, Ian Tomlinson, Rohan Taylor, Chris Jacobs, Rosa Legood, Maria Raikou, Alistair McGuire, Uziel Beller, Usha Menon, Ian Jacobs. J Med Genet 2016
Times Cited: 26







List of co-cited articles
221 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
102
57

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
97
53

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
151
50

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
50

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
135
50

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
803
46


Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Kelly A Metcalfe, Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun, Steven A Narod. J Clin Oncol 2010
110
42

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.
Ranjit Manchanda, Oleg Blyuss, Faiza Gaba, Vladimir Sergeevich Gordeev, Chris Jacobs, Matthew Burnell, Carmen Gan, Rohan Taylor, Clare Turnbull, Rosa Legood,[...]. J Med Genet 2018
20
55

Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Ranjit Manchanda, Shreeya Patel, Antonis C Antoniou, Ephrat Levy-Lahad, Clare Turnbull, D Gareth Evans, John L Hopper, Robert J Macinnis, Usha Menon, Ian Jacobs,[...]. Am J Obstet Gynecol 2017
30
38

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
697
34

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
75
34

Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
K A Metcalfe, A Poll, M Llacuachaqui, S Nanda, A Tulman, N Mian, P Sun, S A Narod. Clin Genet 2010
37
34

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
565
30

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
97
30

Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Anita Y Kinney, Laurie E Steffen, Barbara H Brumbach, Wendy Kohlmann, Ruofei Du, Ji-Hyun Lee, Amanda Gammon, Karin Butler, Saundra S Buys, Antoinette M Stroup,[...]. J Clin Oncol 2016
62
26

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
26

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.
R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, E Benjamin, C Brunell, E Saridogan, S Gessler, D Oram,[...]. BJOG 2012
37
26

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Sari Lieberman, Ariela Tomer, Avi Ben-Chetrit, Oded Olsha, Shalom Strano, Rachel Beeri, Sivan Koka, Hila Fridman, Karen Djemal, Itzhak Glick,[...]. Genet Med 2017
26
26

A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.
Sarah Jervis, Honglin Song, Andrew Lee, Ed Dicks, Patricia Harrington, Caroline Baynes, Ranjit Manchanda, Douglas F Easton, Ian Jacobs, Paul P D Pharoah,[...]. J Med Genet 2015
33
26


Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
388
23

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
72
23

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
173
23

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
259
23


Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
Shreeya Patel, Rosa Legood, D Gareth Evans, Clare Turnbull, Antonis C Antoniou, Usha Menon, Ian Jacobs, Ranjit Manchanda. Am J Obstet Gynecol 2018
18
33

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Sari Lieberman, Amnon Lahad, Ariela Tomer, Carmit Cohen, Ephrat Levy-Lahad, Aviad Raz. Genet Med 2017
18
33

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
42
23

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
R Manchanda, M Burnell, F Gaba, R Desai, J Wardle, S Gessler, L Side, S Sanderson, K Loggenberg, A F Brady,[...]. BJOG 2020
13
46

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
114
19

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
19

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
165
19

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
350
19

Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
73
19

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
Kelly A Metcalfe, Nida Mian, Melissa Enmore, Aletta Poll, Marcia Llacuachaqui, Sonia Nanda, Ping Sun, Kevin S Hughes, Steven A Narod. Breast Cancer Res Treat 2012
54
19

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
338
19

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Erica M Bednar, Holly D Oakley, Charlotte C Sun, Catherine C Burke, Mark F Munsell, Shannon N Westin, Karen H Lu. Gynecol Oncol 2017
28
19

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
54
19

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
158
19

Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
R Manchanda, M Burnell, F Gaba, S Sanderson, K Loggenberg, S Gessler, J Wardle, L Side, R Desai, A F Brady,[...]. BJOG 2019
9
55

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
179
15

What is the price of life and why doesn't it increase at the rate of inflation?
Peter A Ubel, Richard A Hirth, Michael E Chernew, A Mark Fendrick. Arch Intern Med 2003
473
15

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Victor R Grann, Priya R Patel, Judith S Jacobson, Ellen Warner, Daniel F Heitjan, Maxine Ashby-Thompson, Dawn L Hershman, Alfred I Neugut. Breast Cancer Res Treat 2011
68
15

Genetic screening for gynecological cancer: where are we heading?
Ranjit Manchanda, Ian Jacobs. Future Oncol 2016
7
57

Next-generation DNA sequencing.
Jay Shendure, Hanlee Ji. Nat Biotechnol 2008
15

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
98
15


Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
15

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
331
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.